| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $147.3M | — | -3.7% |
| Cost of Revenue | $86.6M | — | -2.7% |
| Gross Profit | $60.7M | — | -5.2% |
| R&D Expense | $4.0M | — | -2.4% |
| SG&A Expense | $35.4M | — | -3.5% |
| Operating Income | $17.5M | — | -9.5% |
| Pre-tax Income | $9.1M | — | +134.7% |
| Income Tax | $1.9M | — | +74.6% |
| Net Income | $7.3M | — | +157.6% |
| EPS (Basic) | $0.06 | — | +200.0% |
| EPS (Diluted) | $0.06 | — | +200.0% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $33.1M | -11.2% | -15.4% |
| Accounts Receivable | $59.1M | +2.0% | +16.1% |
| Inventory | $210.5M | +2.4% | +11.3% |
| Current Assets | $317.9M | +0.6% | +10.3% |
| Total Assets | $1.18B | +1.3% | +3.0% |
| Current Liabilities | $100.3M |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.9M | — | +63.6% |
| Capital Expenditures | $3.5M | — | +16.5% |
| Investing Cash Flow | -$9.8M | — | -26.8% |
| Financing Cash Flow | $9.0M | — | +479.9% |
| Free Cash Flow | -$6.3M | — | +41.6% |
| -0.5% |
| Long-term Debt | $530.8M | +2.9% | -3.7% |
| Total Liabilities | $722.8M | +1.1% | +0.5% |
| Stockholders' Equity | $456.0M | +1.6% | +7.4% |